AstraZeneca

AstraZeneca Stock Jumps 3.5%: Cancer Drugs Beat — and a $2 Billion Overhaul

2026-10-30

AstraZeneca shares rose about 3% in London and 3.5% in U.S. premarket trading on Friday, October 30, 2026, after the British drugmaker beat third-quarter expectations and unveiled a $2 billion rest...